Clinical Trials
3 trialsNCT02990416 2016-12-13
A-dmDT390-bisFv(UCHT1) Fusion Protein With Ionizing Radiation and Pembrolizumab for the Treatment of Stage IV Melanoma
Virogen Biotechnology Inc.
Phase 1/2 Unknown
NCT01888081 2016-11-23
A-dmDT390-bisFv(UCHT1) Fusion Protein in Combination With Ionizing Radiation for Treatment of Stage IV Melanoma
Virogen Biotechnology Inc.
Phase 1/2 Terminated
NCT00132704 2014-07-24
An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation
Memorial Sloan Kettering Cancer Center
Completed